abstract |
The present invention relates to compounds of the formula (I) or pharmaceutically acceptable salts, the Formula (I) wherein R1a, R1b, R1c, X, and Y are as defined in the description. The present invention also relates to compositions containing the compounds, which are useful for inhibiting kinases such as Cdc7 and methods for treating diseases such as cancer. |